[1]
X. Luo, “The Role of PD-1/PD-L1 Inhibitors in the Treatment of Nasopharyngeal Carcinoma in the Epstein-barr Virus Microenvironment”, TMBLS, vol. 7, pp. 448–453, Dec. 2024, doi: 10.62051/c278pb78.